OBJECTIVE: An automated cognitive neurophysiological test is presented that characterizes how an individual was affected by a drug or treatment. The test calculates sub-scores for working memory task performance, cortical activation, and alertness, and combines the sub-scores into an overall score. METHODS: The test was applied in a double-blind, placebo-controlled study of alcohol, caffeine, diphenhydramine, and sleep deprivation in 16 healthy adults. RESULTS: The between- and within-day variability of the sub-scores and overall scores for placebo were all near zero, suggesting that the scores are stable. All treatments affected the overall score, while differential effects on sub-scores highlighted the added value of EEG measures. CONCLUSIONS: The test is sensitive to relatively mild alterations in cognitive function. Its automation makes it suitable for use in large-scale clinical trials. SIGNIFICANCE: By combining task performance with EEG brain function measures, the test may prove to have better sensitivity and specificity in detecting changes due to drugs or other treatments than comparable neuropsychological test batteries that do not directly measure brain function signals.
RCT Entities:
OBJECTIVE: An automated cognitive neurophysiological test is presented that characterizes how an individual was affected by a drug or treatment. The test calculates sub-scores for working memory task performance, cortical activation, and alertness, and combines the sub-scores into an overall score. METHODS: The test was applied in a double-blind, placebo-controlled study of alcohol, caffeine, diphenhydramine, and sleep deprivation in 16 healthy adults. RESULTS: The between- and within-day variability of the sub-scores and overall scores for placebo were all near zero, suggesting that the scores are stable. All treatments affected the overall score, while differential effects on sub-scores highlighted the added value of EEG measures. CONCLUSIONS: The test is sensitive to relatively mild alterations in cognitive function. Its automation makes it suitable for use in large-scale clinical trials. SIGNIFICANCE: By combining task performance with EEG brain function measures, the test may prove to have better sensitivity and specificity in detecting changes due to drugs or other treatments than comparable neuropsychological test batteries that do not directly measure brain function signals.
Authors: G McCarthy; A M Blamire; A Puce; A C Nobre; G Bloch; F Hyder; P Goldman-Rakic; R G Shulman Journal: Proc Natl Acad Sci U S A Date: 1994-08-30 Impact factor: 11.205
Authors: Alan Gevins; Linda K McEvoy; Michael E Smith; Cynthia S Chan; Lita Sam-Vargas; Cliff Baum; Aaron B Ilan Journal: Clin Neurophysiol Date: 2011-12-11 Impact factor: 3.708
Authors: Clete A Kushida; Deborah A Nichols; Tyson H Holmes; Stuart F Quan; James K Walsh; Daniel J Gottlieb; Richard D Simon; Christian Guilleminault; David P White; James L Goodwin; Paula K Schweitzer; Eileen B Leary; Pamela R Hyde; Max Hirshkowitz; Sylvan Green; Linda K McEvoy; Cynthia Chan; Alan Gevins; Gary G Kay; Daniel A Bloch; Tami Crabtree; William C Dement Journal: Sleep Date: 2012-12-01 Impact factor: 5.849
Authors: Hannes Devos; Kathleen Gustafson; Ke Liao; Pedram Ahmadnezhad; Bradley Estes; Laura E Martin; Jonathan D Mahnken; William M Brooks; Jeffrey M Burns Journal: Transl Neurodegener Date: 2022-02-09 Impact factor: 8.014
Authors: Hannes Devos; Jeffrey M Burns; Ke Liao; Pedram Ahmadnezhad; Jonathan D Mahnken; William M Brooks; Kathleen Gustafson Journal: Front Aging Neurosci Date: 2020-10-19 Impact factor: 5.750